FierceBiotech ٢٢ أبريل ٢٠٢٦ Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Insilico Medicine ٢١ أبريل ٢٠٢٦ Insilico Medicine and Eli Lilly and Company Partner on AI-Driven Drug Discovery - CDO Magazine
BioPharma Dive ١٧ أبريل ٢٠٢٦ Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
BioPharma Dive ٨ أبريل ٢٠٢٦ Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure
FierceBiotech ٧ أبريل ٢٠٢٦ Lilly pays AC Immune $12.5M to expand Alzheimer’s collab as asset draws closer to clinic
Endpoints News ٢ أبريل ٢٠٢٦ Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
Endpoints News ٢ أبريل ٢٠٢٦ Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Endpoints News ١ أبريل ٢٠٢٦ Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
FierceBiotech ٣١ مارس ٢٠٢٦ Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play